The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report.

IF 2.2 4区医学 Q3 HEMATOLOGY

Leukemia & Lymphoma Pub Date : 2024-07-29 DOI:10.1080/10428194.2024.2385498

Yu Jeong Choi, Hye Won Kook, Seung-Tae Lee, Jaewoo Song, Jong Rak Choi, June-Won Cheong, Saeam Shin

引用次数: 0

查看原文本刊更多论文

基于新一代测序的最小残留病监测在骨髓增生性肿瘤后急性髓性白血病患者中的应用：一份病例报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia & Lymphoma 医学-血液学

CiteScore

4.10

自引率

3.80%

发文量

384

审稿时长

1.8 months

期刊介绍： Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor

文献相关原料

公司名称	产品信息	采购帮参考价格